Hap Trading, LLC Viatris Inc Put Options Transaction History

Hap Trading, LLC

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2023 Aug 11, 2023	BUY	$9.02 - $10.29 $105,534 - $120,392	11,700 New	11,700 $116,000
Q4 2022 Feb 14, 2023	SELL	$8.72 - $11.56 $85,456 - $113,288	-9,800 Reduced 29.08%	23,900 $17,000
Q3 2022 Nov 14, 2022	SELL	$8.48 - $11.13 $164,512 - $215,922	-19,400 Reduced 36.53%	33,700 $127,000
Q2 2022 Aug 12, 2022	BUY	$9.95 - $12.27 $52,734 - $65,031	5,300 Added 11.09%	53,100 $157,000
Q1 2022 May 12, 2022	SELL	$9.81 - $15.4 $569,961 - $894,740	-58,100 Reduced 54.86%	47,800 $158,000
Q4 2021 Feb 14, 2022	BUY	$12.09 - $14.68 $612,963 - $744,276	50,700 Added 91.85%	105,900 $78,000
Q3 2021 Nov 10, 2021	BUY	$13.25 - $15.13 $279,575 - $319,243	21,100 Added 61.88%	55,200 $64,000
Q2 2021 Aug 11, 2021	BUY	$12.97 - $16.15 $442,277 - $550,715	34,100 New	34,100 $25,000
Q1 2021 May 14, 2021	SELL	$13.59 - $18.54 $8.28 Million - $11.3 Million	-609,600 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$14.3 - $18.74 $8.72 Million - $11.4 Million	609,600 New	609,600 $886,000

1,102

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.